Tenaya Therapeutics, Inc.
TNYA
$0.79
-$0.05-6.06%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/25/2025
-
MarketBeat
1/30/2026
-
TipRanks Financial Blog
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Recommendation of "Moderate Buy" by Analysts
1/23/2026
-
MarketBeat
Tenaya Therapeutics (TNYA) Valuation After 2026 Gene Therapy Updates And US$60 Million Capital Raise
1/22/2026
-
Simply Wall St
1/21/2026
-
Simply Wall St
1/19/2026
-
Yahoo! Finance: News
1/16/2026
-
Insider Monkey
1/12/2026
-
Yahoo! Finance: News
1/12/2026
-
Insider Monkey
1/10/2026
-
Insider Monkey
1/9/2026
-
GuruFocus
1/9/2026
-
GuruFocus
1/9/2026
-
TipRanks Financial Blog
1/9/2026
-
The Fly
1/9/2026
-
Globe Newswire
1/8/2026
-
The Fly
1/2/2026
-
TipRanks Financial Blog
12/29/2025
-
MarketBeat
12/20/2025
-
TipRanks Financial Blog
12/18/2025
-
MarketBeat
12/18/2025
-
The Fly
12/13/2025
-
MarketBeat
12/13/2025
-
Simply Wall St
12/13/2025
-
MarketBeat
12/12/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 825 6990
Address
171 Oyster Point Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company’s lead product candidate...
more